The Effect of Preoperative Immunonutrition on Surgical Outcomes in Patients Undergoing Resection for Pancreatic Malignancy

Pancreatic cancer is the seventh leading cause of global cancer-related mortality [1], and the fourth leading in Australia [2]. Despite early detection and treatment, the five-year survival rate for a diagnosis of pancreatic malignancy remains significantly low at 9% [1-3]. Currently, the single